What happened
Shares of IT monitoring software company Datadog (NASDAQ: DDOG) surged 22% in June, according to data from S&P Global Market Intelligence. The June performance was all the more impressive considering it came on the heels of a 58% gain during the month of May.
Millions of Americans have lost their jobs in the wake of COVID-19, and for some, that means a loss of health insurance, as well as a paycheck. But not everyone gets health insurance through work. Some people get their insurance through the healthcare exchange, and under the Aff
While the COVID-19 pandemic has put many smaller companies in danger of going out of business, large companies with rock-solid balance sheets are looking good these days. In difficult times, big companies with lots of cash can take advantage by investing through a downcycle to t
ExxonMobil's (NYSE: XOM) stock has fallen by more than a third so far in 2020, and its yield is up to a historically high 7.7%. There are very real issues facing this energy giant today, which is why the shares are down and the yield is up. But despite the headwinds, it's still
Most of us are pretty good at coming up with excuses while we put off doing important things. Our tires might need more air, for example, but it looks like rain today, so maybe we'll aim to fill them tomorrow. We should go for a walk or run, but it's very hot out.
The year 2020 is seeing some new investment areas that became the hottest trends, thanks to the coronavirus outbreak. These trends are largely the by-products of quarantine measures and efforts to minimize the human-to-human contact, which are absolutely necessary to control the
Withdrawing money from a 401(k) before age 59 1/2 is usually an extremely expensive proposition since you're hit with a 10% tax penalty on your early distribution.
At the end of April, shares of Gilead Sciences (NASDAQ: GILD) were hovering near their 52-week highs of $85.97. The stock has been falling since then, and it's now trading at just about $76. Year to date, the stock is still up 17%, and well above the 4% decline the S&P 500
Inovio Pharmaceuticals (NASDAQ: INO) has been grabbing a lot of headlines over the past few weeks, mostly thanks to its involvement in the race to find a vaccine for COVID-19. The company claimed to have come up with its potential vaccine, INO-4800, in a mere three hours after C
It's been a rocky few months and an unquestionably difficult year for most of us thus far, but that doesn't change the fact that we're midway through 2020 and it's time to give your finances a closer look. Here are a few moves to make so you can see where you stand regarding mon
Taxes. No one likes to pay them. Unfortunately, that old adage about death and taxes rings as true today as it ever has. Investment income is not spared either, but there are ways to decrease these taxes, or stop them from hindering the growth of your wealth through time.
When positioning your retirement fund for the long-term horizon, perhaps three or four decades down the road, be sure to save room in your portfolio for environmental, social, and governance (ESG) stocks. Sure, these companies may involve novel strategies and may not be as well
Buying a dividend stock that's cheap can be a great way to maximize the returns you'll make from owning it. Not only will you earn dividend income, but you can also benefit if the stock rises in value. And the cheaper the stock is, the more the potential upside there is.
The COVID-19 crisis has done a number on the U.S. economy, and we're now in a recession that could easily last well into 2021. In light of that, you might assume that now's a terrible time to invest, when actually, the opposite is true.
There's no question that this has been a challenging year for all Americans. The coronavirus disease 2019 (COVID-19) pandemic has completely upended societal norms, driven more than 20 million people out of work, and caused a level of panic and uncertainty that hasn't been seen